Essential hypertension - Is erroneous receptor output to blame?

Medical Hypotheses

Volumn 78, Issue 4, 2012, Pages 454-458

  Ufnal, Marcin ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; ARTERIAL PRESSURE; ARTICLE; BLEEDING; BLOOD VESSEL; CARDIOVASCULAR SYSTEM; CHEMORECEPTOR; COMORBIDITY; DEPRESSION; ESSENTIAL HYPERTENSION; HEART; HUMAN; KIDNEY; NERVOUS SYSTEM; PRESSORECEPTOR;

AFFERENT PATHWAYS; BLOOD PRESSURE; BRAIN; HUMANS; HYPERTENSION; MODELS, BIOLOGICAL; PRESSORECEPTORS;

EID: 84858153169     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.12.019     Document Type: Article

References (61)

1. Montani J.P., Van Vliet B.N. Understanding the contribution of Guyton's large circulatory model to long-term control of arterial pressure. Exp Physiol 2009, 94:382-388.
2. Osborn J.W., Averina V.A., Fink G.D. Commentary on 'understanding the contribution of Guyton's large circulatory model to long-term control of arterial pressure'. Exp Physiol 2009, 94:388-389.
3. Guyton A.C., Hall J.E., Lohmeier T.E., Jackson T.E., Kastner P.R. Blood pressure regulation: basic concepts. Fed Proc 1981, 40:2252-2256.
4. Guyton A.C., Coleman T.G., Cowley A.V., Scheel K.W., Manning R.D., Norman R.A. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 1972, 52:584-594.
5. Guyton A.C. Renal function curves and control of body fluids and arterial pressure. Acta Physiol Scand Suppl 1990, 591:107-113.
6. Scheffers I.J., Kroon A.A., Schmidli J., Jordan J., Tordoir J.J., Mohaupt M.G., et al. Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol 2010, 56:1254-1258.
7. Lohmeier T.E., Dwyer T.M., Irwin E.D., Rossing M.A., Kieval R.S. Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension 2007, 49:1307-1314.
8. Lohmeier T.E., Hildebrandt D.A., Dwyer T.M., Iliescu R., Irwin E.D., Cates A.W., et al. Prolonged activation of the baroreflex decreases arterial pressure even during chronic adrenergic blockade. Hypertension 2009, 53:833-838.
9. Lohmeier T.E., Iliescu R., Dwyer T.M., Irwin E.D., Cates A.W., Rossing M.A. Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex. Am J Physiol Heart Circ Physiol 2010, 299:H402-H409.
10. Schlaich M.P., Krum H., Sobotka P.A. Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension. Curr Hypertens Rep 2010, 12:39-46.
11. Veerasingham S.J., Raizada M.K. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 2003, 139:191-202.
12. Esler M., Schwarz R. Management of hypertension complicated by psychiatric comorbidity. J Clin Hypertens (Greenwich) 2007, 9:708-713.
13. Bai Y., Jabbari B., Ye S., Campese V.M., Vaziri N.D. Regional expression of NAD(P)H oxidase and superoxide dismutase in the brain of rats with neurogenic hypertension. Am J Nephrol 2009, 29:483-492.
14. Davern P.J., Head G.A. Fos-related antigen immunoreactivity after acute and chronic angiotensin II-induced hypertension in the rabbit brain. Hypertension 2007, 49:1170-1177.
15. Johannessen L., Strudsholm U., Foldager L., Munk-Jorgensen P. Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia. J Affect Disord 2006, 95:13-17.
16. Bernard C. Influence du grand sympathique sur la sensibilité et sur la calorification. C R Soc Biol (Paris) 1851, 3:163-170.
17. Schiff M. Ueber den Einfluss der Nerven auf die Gefässe der Zunge. Arch Physiol Heilk 1853, 12:377-381.
18. Dampney R.A. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994, 74:323-364.
19. Loewy A.D. Viruses as transneuronal tracers for defining neural circuits. Neurosci Biobehav Rev 1998, 22:679-684.
20. Spyer K.M., Lambert J.H., Thomas T. Central nervous system control of cardiovascular function: neural mechanisms and novel modulators. Clin Exp Pharmacol Physiol 1997, 24:743-747.
21. Bohr D.F. What makes the pressure go up? A hypothesis. Hypertension 1981, 3:II-160-165.
22. Osborn J.W. Hypothesis: set-points and long-term control of arterial pressure. A theoretical argument for a long-term arterial pressure control system in the brain rather than the kidney. Clin Exp Pharmacol Physiol 2005, 32:384-393.
23. Teufert K.B., Doherty J. Endolymphatic sac shunt, labyrinthectomy, and vestibular nerve section in Meniere's disease. Otolaryngol Clin North Am 2010, 43:1091-1111.
24. Guyton A.C., Hall J.E. Textbook of medical physiology 2006, Elsevier, Saunders, Philadelphia.
25. Bonyhay I., Jokkel G., Kollai M. Relation between baroreflex sensitivity and carotid artery elasticity in healthy humans. Am J Physiol 1996, 271:H1139-H1144.
26. Angell-James J.E. Characteristics of single aortic and right subclavian baroreceptor fiber activity in rabbits with chronic renal hypertension. Circ Res 1973, 32:149-161.
27. Shkhvatsabaya I.K., Yasinovskaya F.P., Anyukhovskiy E.P. Resetting of aortic baroreceptors in experimental hypertension and atherosclerosis. Cor Vasa 1977, 19:43-52.
28. Angell-James J.E. Arterial baroreceptor activity in rabbits with experimental atherosclerosis. Circ Res 1974, 40:27-39.
29. Cai G.J., Miao C.Y., Xie H.H., Lu L.H., Su D.F. Arterial baroreflex dysfunction promotes atherosclerosis in rats. Atherosclerosis 2005, 183:41-47.
30. Nasr N., Pavy-Le Traon A., Larrue V. Baroreflex sensitivity is impaired in bilateral carotid atherosclerosis. Stroke 2005, 36:1891-1895.
31. Vlachakis N.D., Mendlowitz M., DGuia D., DGusman D. Diminished baroreceptor sensitivity in elderly hypertensives. Possible role of atherosclerosis. Atherosclerosis 1976, 24:243-249.
32. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
33. Chapleau M.W., Cunningham J.T., Sullivan M.J., Wachtel R.E., Abboud F.M. Structural versus functional modulation of the arterial baroreflex. Hypertension 1995, 26:341-347.
34. Ruiz J., Monbaron D., Parati G., Perret S., Haesler E., Danzeisen C., et al. Diabetic neuropathy is a more important determinant of baroreflex sensitivity than carotid elasticity in type 2 diabetes. Hypertension 2005, 46:162-167.
35. Sanya E.O., Tutaj M., Brown C.M., Goel N., Neundorfer B., Hilz M.J. Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients. Clin Auton Res 2005, 15:213-218.
36. Cowley A.W., DeClue J.W. Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotension-induced hypertension in dogs. Circ Res 1976, 39:779-787.
37. Andresen M.C., Yang M. Arterial baroreceptor resetting: contributions of chronic and acute processes. Clin Exp Pharmacol Physiol Suppl 1989, 15:19-30.
38. Thrasher T.N. Unloading arterial baroreceptors causes neurogenic hypertension. Am J Physiol Regul Integr Comp Physiol 2002, 282:R1044-R1053.
39. Gonzalez C., Almaraz L., Obeso A., Rigual R. Carotid body chemoreceptors: from natural stimuli to sensory discharges. Physiol Rev 1994, 74:829-898.
40. Kumar P. Sensing hypoxia in the carotid body: from stimulus to response. Essays Biochem 2007, 43:43-60.
41. Iturriaga R., Moya E.A., Del Rio R. Carotid body potentiation induced by intermittent hypoxia: implications for cardiorespiratory changes induced by sleep apnoea. Clin Exp Pharmacol Physiol 2009, 36:1197-1204.
42. Bosc L.V., Resta T., Walker B., Kanagy N.L. Mechanisms of intermittent hypoxia induced hypertension. J Cell Mol Med 2010, 14:3-17.
43. Weiss J.W., Liu M.D., Huang J. Physiological basis for a causal relationship of obstructive sleep apnoea to hypertension. Exp Physiol 2007, 92:21-26.
44. Cottrell G.T., Ferguson A.V. Sensory circumventricular organs: central roles in integrated autonomic regulation. Regul Pept 2004, 117:11-23.
45. Ganong W.F. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol 2000, 27:422-427.
46. Duvernoy H.M., Risold P.Y. The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res Rev 2007, 56:119-147.
47. Chen M., Lee J., Malvin R.L. Central administration of aldosterone increases blood pressure in rats. Clin Exp Hypertens A 1989, 11:459-472.
48. Gomez-Sanchez E.P. Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology 1986, 118:819-823.
49. Schoelkens B.A., Jung W., Steinback R. Blood pressure response to central and peripheral injection of angiotensin II and 8-C-phenylglycine analogue of angiotensin II in rats with experimental hypertension. Clin Sci Mol Med Suppl 1976, 3:403s-406s.
50. Ufnal M., Sikora M., Zera T., Szczepanska-Sadowska E. Simvastatin reduces pressor response to centrally administered angiotensin II. Am J Hypertens 2010, 23:956-959.
51. Zerbe R.L., Feuerstein G. Cardiovascular effects of centrally administered vasopressin in conscious and anesthetized rats. Neuropeptides 1985, 6:471-483.
52. Zera T., Ufnal M. Enhanced pressor response to centrally administered vasopressin in WKY rats on high sodium diet. Acta Neurobiol Exp (Wars) 2005, 65:145-150.
53. Kawano Y., Yoshida K., Yoshimi H., Kuramochi M., Omae T. The cardiovascular effect of intracerebroventricular endothelin in rats. J Hypertens Suppl 1989, 7:S22-S23.
54. Nishimura M., Takahashi H., Matsusawa M., Ikegaki I., Nakanishi T., Hirabayashi M., et al. Intracerebroventricular injections of endothelin increase arterial pressure in conscious rats. Jpn Circ J 1990, 54:662-670.
55. Ufnal M., Dudek M., Zera T., Szczepanska-Sadowska E. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II. Brain Res 2006, 1100:64-72.
56. Mayer M.A., Giani J.F., Hocht C., Silberman E.A., Munoz M.C., Taira C.A., et al. Centrally administered insulin potentiates the pressor response to angiotensin II. Regul Pept 2010, 163:57-61.
57. Scheuer D.A., Bechtold A.G. Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure. Am J Physiol Regul Integr Comp Physiol 2001, 280:R1719-R1726.
58. Oparil S., Sripairojthikoon W., Wyss J.M. The renal afferent nerves in the pathogenesis of hypertension. Can J Physiol Pharmacol 1987, 65:1548-1558.
59. Ye S., Ozgur B., Campese V.M. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 1997, 51:722-727.
60. Wyss J.M., Aboukarsh N., Oparil S. Sensory denervation of the kidney attenuates renovascular hypertension in the rat. Am J Physiol 1986, 250:H82-H86.
61. Campese V.M., Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 1995, 25:878-882.